Analysis of future development trend of pharmaceutical machinery

In recent years, with the improvement of the level of the main machine in China, the bottleneck phenomenon of the mechanical basic parts lagging behind the main machine is increasingly serious Because of the late recognition of the position of pharmaceutical equipment in the mechanical industry and the long-term lack of investment, the whole industry has poor foundation, weak foundation, weak actual strength and other problems In recent years, China's pharmaceutical machinery industry has not been able to digest, absorb and create well when introducing international equipment, strengthen the ability of independent innovation in market analysis, and grasp the first opportunity of the market Therefore, it has been following the foreign enterprises, without competitive advantage and market initiative       Domestic pharmaceutical machinery production is still dominated by low-grade products, and a small part of secondary, high-precision and high-strength equipment still needs to be imported The ratio gap between the import unit price and the export unit price is more than 6 times, and the gap between the import unit price and the export unit price is larger than that of the United States, Japan, South Korea and Taiwan Moreover, there is a lack of technical services and mechanical fastening solutions to achieve product, design, manufacturing and management Digital, green products and manufacturing processes The technical content of the product is reflected in the processing technology and technical equipment Technology is the core means, equipment is the key to R & D, verification and manufacturing, and pharmaceutical machinery plays a leading role in pharmaceutical technology Although a large number of imports have reduced the distance between China and foreign advanced equipment However, the advanced R & D capabilities of foreign countries have not been mastered by us The R & D achievements are endless, and the R & D trend is becoming increasingly diverse If we always follow the foreign advantageous enterprises, we will always be able to do supporting processing in the inevitable trend of socialized mass production, but we cannot make the brand rise, and cannot revitalize the national industry What foreign advanced pharmaceutical machinery enterprises sell to us is the added value of technology and service, and what we absorb is the growth of mass production, renewal of equipment and expansion of scale, which has to cause our deep thinking Compared with 2012, the pressure of China's pharmaceutical machinery industry will slow down, and slow growth will become a trend.